DK0584368T3 - Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistof - Google Patents

Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistof

Info

Publication number: DK0584368T3
Authority: DK; Denmark
Prior art keywords: inhibitor; antibody; cell adhesion; metastasis; preparing
Prior art date: 1992-02-14

Application number

DK93904304T

Other languages

Danish (da)

English (en)

Inventor

Jyunko Suntory Inst Fo Hashino

Shinzo Suntory Inst For Oikama

Hiroshi Suntory Inst Nakazato

Toshihiro Suntory In Nakanishi

Original Assignee

Suntory Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-02-14

Filing date

1993-02-12

Publication date

2002-06-17

1993-02-12 Application filed by Suntory Ltd filed Critical Suntory Ltd

2002-06-17 Application granted granted Critical

2002-06-17 Publication of DK0584368T3 publication Critical patent/DK0584368T3/da

Links

230000021164 cell adhesion Effects 0.000 title abstract 3
239000003112 inhibitor Substances 0.000 title abstract 3
239000002257 antimetastatic agent Substances 0.000 title abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 3
201000011510 cancer Diseases 0.000 abstract 3
108090000765 processed proteins & peptides Proteins 0.000 abstract 3
102000012406 Carcinoembryonic Antigen Human genes 0.000 abstract 1
108010022366 Carcinoembryonic Antigen Proteins 0.000 abstract 1
102000003886 Glycoproteins Human genes 0.000 abstract 1
108090000288 Glycoproteins Proteins 0.000 abstract 1
206010027476 Metastases Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
230000009401 metastasis Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Oncology (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Toxicology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

DK93904304T 1992-02-14 1993-02-12 Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistof DK0584368T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP5955192		1992-02-14
PCT/JP1993/000182 WO1993016193A1 (fr)	1992-02-14	1993-02-12	Anticorps inhibant l'adhesion cellulaire et inhibiteur d'adhesion cellulaire le contenant

Publications (1)

Publication Number	Publication Date
DK0584368T3 true DK0584368T3 (da)	2002-06-17

Family

ID=13116505

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93904304T DK0584368T3 (da)	1992-02-14	1993-02-12	Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistof

Country Status (9)

Country	Link
US (1)	US5648078A (fr)
EP (1)	EP0584368B1 (fr)
JP (1)	JP3483556B2 (fr)
AT (1)	ATE217909T1 (fr)
DE (1)	DE69331942T2 (fr)
DK (1)	DK0584368T3 (fr)
ES (1)	ES2177540T3 (fr)
PT (1)	PT584368E (fr)
WO (1)	WO1993016193A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2506499A (en) *	1998-02-12	1999-08-30	Mcgill University	Cea/nca-based differentiation cancer therapy
CA2500978A1 (fr) *	2002-10-03	2004-04-15	Mcgill University	Agents de liaison d'antigenes carcinoembryonnaires (cea) permettant d'inverser les effets tumorigenes a mediation cea sur des cellules cancereuses humaines et leurs utilisations
AU2011252699B2 (en)	2010-05-11	2015-09-17	Governing Council Of The University Of Toronto	The N-domain of carcinoembryonic antigen and compositions, methods and uses thereof
US9753036B2 (en) *	2014-04-29	2017-09-05	Edp Biotech Corporation	Methods and compositions for screening and detecting biomarkers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4348376A (en) *	1980-03-03	1982-09-07	Goldenberg Milton David	Tumor localization and therapy with labeled anti-CEA antibody
JPH0811075B2 (ja) *	1982-06-30	1996-02-07	雄治松岡	単クローン性抗ｃｅａ抗体
JP2607492B2 (ja) *	1987-01-14	1997-05-07	サントリー株式会社	ヒト癌胎児性抗原
GB8800078D0 (en) *	1988-01-05	1988-02-10	Ciba Geigy Ag	Novel antibodies
GB9014932D0 (en) *	1990-07-05	1990-08-22	Celltech Ltd	Recombinant dna product and method
JPH05119037A (ja) *	1991-08-08	1993-05-14	Suntory Ltd	ヒト癌胎児性抗原の免疫測定法

1993
- 1993-02-12 WO PCT/JP1993/000182 patent/WO1993016193A1/fr active IP Right Grant
- 1993-02-12 DE DE69331942T patent/DE69331942T2/de not_active Expired - Fee Related
- 1993-02-12 JP JP51395293A patent/JP3483556B2/ja not_active Expired - Fee Related
- 1993-02-12 AT AT93904304T patent/ATE217909T1/de not_active IP Right Cessation
- 1993-02-12 EP EP93904304A patent/EP0584368B1/fr not_active Expired - Lifetime
- 1993-02-12 US US08/129,195 patent/US5648078A/en not_active Expired - Fee Related
- 1993-02-12 ES ES93904304T patent/ES2177540T3/es not_active Expired - Lifetime
- 1993-02-12 DK DK93904304T patent/DK0584368T3/da active
- 1993-02-12 PT PT93904304T patent/PT584368E/pt unknown

Also Published As

Publication number	Publication date
DE69331942D1 (de)	2002-06-27
WO1993016193A1 (fr)	1993-08-19
US5648078A (en)	1997-07-15
EP0584368A4 (en)	1996-07-03
ES2177540T3 (es)	2002-12-16
EP0584368B1 (fr)	2002-05-22
ATE217909T1 (de)	2002-06-15
JP3483556B2 (ja)	2004-01-06
DE69331942T2 (de)	2002-10-02
PT584368E (pt)	2002-10-31
EP0584368A1 (fr)	1994-03-02

Similar Documents

Publication	Publication Date	Title
AR243234A1 (es)	1993-07-30	Un gen quimerico modificado que codifica una proteina insecticida de bacillus thuringiensis,un vector que lo contiene, y un metodo para mejorar la expresion de un gen heterologo.
IT7924401A0 (it)	1979-07-17	Procedimento per la purificazione e coltivazione sequenziale di cristalli di silicio.
GEP20105119B (en)	2010-11-25	Chimeric anti-cd20 antibody
TR199801253T2 (xx)	1998-12-21	Vitronektin resept�r� antagonistleri.
DE69003804D1 (de)	1993-11-11	Fentanyl enthaltende aerosolzubereitungen.
ATE47711T1 (de)	1989-11-15	Biologisch aktive verbindung mit anti-prolyl endopeptidasewirkung.
DE3581514D1 (de)	1991-02-28	Film zur behandlung von halbleiterwaffeln.
NO177700C (no)	1995-11-08	Analogifremgangsmåte for fremstilling av terapeutisk aktive, hydroksaminsyrebaserte kollagenaseinhibitorforbindelser, samt mellomprodukter til anvendelse i framgangsmåten
BG101966A (en)	1998-09-30	Application of 1l-agonist for the treatment of lack of urine retention
IT1229181B (it)	1991-07-23	Mezzi di trasporto per buste.
EP0982988A4 (fr)	2000-04-05	Zonuline pratiquement pure, modulateur physiologique des jonctions serrees mammaliennes
DE69630955T2 (de)	2004-10-21	Immortalisierung bzw. desimmortalisierung von zellen
IT8220139A0 (it)	1982-03-12	Procedimento di micro-incapsulamento, particolarmente di colture di cellule.
EP0396505A3 (fr)	1991-04-03	Anticorps monoclonaux spécifiques pour un isotype d'immunoglobuline
DK0584368T3 (da)	2002-06-17	Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistof
NO850027L (no)	1986-07-04	Overflateaktiv forbindelse og emulsjon inneholdende denne, samt anvendelse derav.
IT1231727B (it)	1991-12-21	Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone.
DE59309740D1 (de)	1999-09-23	Lyopilisierte, wirkstoffhaltige emulsion
NO875199L (no)	1988-06-16	Renin-inhibitorer.
NO891713D0 (no)	1989-04-25	Monoklonale antistoffer til vevplasminogenaktivator (t-pa)
NO875381D0 (no)	1987-12-22	Renininhibitorer.
IT1142141B (it)	1986-10-08	Procedimento e substrato di fermentazione
NO904302L (no)	1990-10-03	Peptidinhibitorer til hiv-induserte cellefusjoner og syncytia-dannelse.
FI941394A0 (fi)	1994-03-25	Peptidejä,jotka kykenevät säätelemään akrosomireaktiota
IT8125461A0 (it)	1981-12-04	Enzima terapeuticamente utile eprocedimento per la sua preparazione.